Advanced wound care, made personal

A lightweight device, that fits seamlessly into standard of care A lightweight device, that fits seamlessly into standard of care
Swiss Medical Technology

A lightweight device, that fits seamlessly into standard of care

Get to know our product

The benefits of COMS®-Technology*

Treatment of chronic wounds represents a challenge for both the patient and modern healthcare systems

How it works
Accelerated Wound Closure

Accelerated Wound Closure

To produce a durable closure for hard-to-heal wounds.

Ease of Use

Ease of Use

Treatment is non-invasive and requires minimal staff supervision.

Decreased Costs

Decreased Costs

Healing of chronic wounds significantly decreases the financial burden of modern health care.

Platform Technology

Platform Technology

The underlying mechanism of action can be applied to different pathological conditions.


*The COMS® One therapy system is not cleared in the US.

Who are we?

Who are we?

We are a young company founded and based in Zurich, Switzerland since 2016. The Piomic family consists of biologists, engineers, entrepreneurs, designers, seniors and a broad group of supporters. Staffed with experts from different backgrounds and a common goal: By developing a therapy which is safe and effective, we want to set a better future for patients in need.

More about us

Do you want to contribute to our vision?

Do you want to contribute to our vision?

In order to maximize our global impact, we are looking for investors who share our vision and wish to shape the future of wound care with us.

Information for investors

Latest news

The COMS® One Therapy System Receives CE Mark

15 May 2020

Piomic Medical, has received CE certification for its Class IIa medical device. The COMS One Therapy System is intended to promote wound healing in chronic leg and foot ulcers.

Read more
The COMS® One Therapy System Receives CE Mark
Piomic is supported by the SME instrument

13 Nov 2019

Piomic was chosen for the SME instrument and funded under grant agreement No. 886276 from the European Union’s Horizon 2020 research and innovation programme.

Read more
Piomic is supported by the SME instrument
Guest Speaker @EWMA 2019

06 Jun 2019

Chief scientific officer Marc Augsburger joining a #EWMAMasterclass to elaborate on the role of molecular oxygen in wound healing.

Read more
Guest Speaker @EWMA 2019
Winner W.A. De Vigier Startup Award 2019

28 May 2019

Piomic is very proud to be among the winners of the W.A. De Vigier Startup Award 2019.

Read more
Winner W.A. De Vigier Startup Award 2019
Don't miss our updates!
You must complete your email.
You must accept our Privacy Policy

Our Partners

Do you want to cooperate with us?

We are constantly trying to expand our interdisciplinary know-how and increase the impact of our novel technology on the lives of patients. Therefore we are looking to conncet to the brightest minds in their field of expertise and share our knowledge to create easy-to-use products and innovative wound care solutions.